RAD51D and prostate cancer: Secondary mutations in BRCA1/2, RAD51 C, RAD51D, and PALB2 are common which restores the functional protein have been reported in many cancer models including breast, ovarian, pancreatic, and prostate cancers (reviewed in [84].